doi: 10.5732/cjc.013.10207
Standards of care and novel approaches in the management of glioblastoma multiforme
Andreas F. Hottinger, Roger Stupp, Krisztian Homicsko
Department of Clinical Neuroscience, Lausanne University Hospital, Lausanne 1011, Switzerland
[Abstract] Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. Standard therapeutic approaches provide modest improvement in the progression-free and overall survival, necessitating the investigation of novel therapies. We review the standard treatment options for GBM and evaluate the results obtained in clinical trials for promising novel approaches, including the inhibition of angiogenesis, targeted approaches against molecular pathways, immunotherapies, and local treatment with low voltage electric fields.
Chinese Journal of Cancer 2014, Volume: 33, Issue 1, Page: 32-39
[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Andreas F. Hottinger, Roger Stupp, Krisztian Homicsko. Standards of care and novel approaches in the management of glioblastoma multiforme. Chin J Cancer. 2014, 33(1):32-39. doi:10.5732/cjc.013.10207
Export citations
EndNote
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Andreas F. Hottinger, Roger Stupp, Krisztian Homicsko. Standards of care and novel approaches in the management of glioblastoma multiforme. Chin J Cancer. 2014, 33(1):32-39. doi:10.5732/cjc.013.10207
Export citations
EndNote
SHARE THIS ARTICLE
Comments: